Enhanced oral bioavailability of docetaxel by coadministration of cyclosporine: Quantitation and role of P-glycoprotein

被引:9
|
作者
Chiou, WL [1 ]
Wu, TC [1 ]
Ma, C [1 ]
Jeong, HY [1 ]
机构
[1] Univ Illinois, Chicago, IL 60607 USA
关键词
D O I
10.1200/JCO.2002.20.7.1951
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1951 / 1952
页数:2
相关论文
共 50 条
  • [1] Enhanced oral bioavailability of docetaxel by coadministration of cyclosporine:: Quantitation and role of P-glycoprotein -: Reply
    Malingré, MM
    Beijnen, JH
    Schellens, JHM
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) : 1952 - 1952
  • [2] Enhanced oral bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor KR30031
    Woo, JS
    Lee, CH
    Shim, CK
    Hwang, SJ
    PHARMACEUTICAL RESEARCH, 2003, 20 (01) : 24 - 30
  • [3] Enhanced Oral Bioavailability of Paclitaxel by Coadministration of the P-Glycoprotein Inhibitor KR30031
    Jong Soo Woo
    Chang Hyun Lee
    Chang Koo Shim
    Sung-Joo Hwang
    Pharmaceutical Research, 2003, 20 : 24 - 30
  • [4] Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel
    Malingré, MM
    Richel, DJ
    Beijnen, JH
    Rosing, H
    Koopman, FJ
    Huinink, WWTB
    Schot, ME
    Schellens, JHM
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) : 1160 - 1166
  • [5] Altered oral bioavailability and pharmacokinetics of P-glycoprotein substrates by coadministration of biochanin A
    Peng, Sean X.
    Ritchie, David M.
    Cousineau, Martin
    Danser, Earl
    Dewire, Robert
    Floden, Jane
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (09) : 1984 - 1993
  • [6] Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine
    Lown, KS
    Mayo, RR
    Leichtman, AB
    Hsiao, HL
    Turgeon, DK
    SchmiedlinRen, P
    Brown, MB
    Guo, WS
    Rossi, SJ
    Benet, LZ
    Watkins, PB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (03) : 248 - 260
  • [7] Oral bioavailability and intestinal secretion of amitriptyline: Role of P-glycoprotein?
    Abaut, Anne-Yvonne
    Chevanne, Francois
    Le Corre, Pascal
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 330 (1-2) : 121 - 128
  • [8] Investigation of the Functional Role of P-Glycoprotein in Limiting the Oral Bioavailability of Lumefantrine
    Wahajuddin
    Raju, Kanumuri S. R.
    Singh, Sheelendra P.
    Taneja, Isha
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (01) : 489 - 494
  • [9] Oral bioavailability of digoxin is enhanced by talinolol: Evidence for involvement of intestinal P-glycoprotein
    Westphal, K
    Weinbrenner, A
    Giessmann, T
    Stuhr, M
    Franke, G
    Zschiesche, M
    Oertel, R
    Terhaag, B
    Kroemer, HK
    Siegmund, W
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (01) : 6 - 12
  • [10] Pharmacokinetic role of P-glycoprotein in oral bioavailability and intestinal secretion of grepafloxacin in vivo
    Yamaguchi, H
    Yano, I
    Saito, H
    Inui, KI
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (03): : 1063 - 1069